tradingkey.logo
tradingkey.logo
Search

Zimmer Biomet Holdings Inc

ZBH
Add to Watchlist
93.930USD
-1.020-1.07%
Close 07-31 16:00ETQuotes delayed by 15 min
18.17BMarket Cap
24.29P/E TTM

Earnings Forecast

Currency: USD Updated: 2026-07-31
Previous score
6.58
Change
0
The current earnings forecast score of Zimmer Biomet Holdings Inc is 6.58, ranking 167 out of 199 in the Healthcare Equipment & Supplies industry. The average price target is 100.00, with a high of 125.00 and a low of 88.00.

Analyst Rating

Based on 29 analysts
Hold
Current Rating
99.720
Target Price
+2.64%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Zimmer Biomet Holdings Inc
ZBH
29
Medtronic PLC
MDT
33
Dexcom Inc
DXCM
31
Stryker Corp
SYK
30
Abbott Laboratories
ABT
29
Medline Ord Shs Class A
MDLN
29
1
2
3
...
22

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Forecast
Actual

FAQs

What is Zimmer Biomet Holdings Inc's expected revenue for the next quarter?

Zimmer Biomet Holdings Inc's expected revenue is 2.13B.

What is Zimmer Biomet Holdings Inc's price target?

Analysts forecast that Zimmer Biomet Holdings Inc's price target is USD 100.00, with the highest forecast at USD 125.00 and the lowest forecast at USD 88.00.

How have Zimmer Biomet Holdings IncZBH's recent earnings per share performed?

The market expectation was USD 1.22, while Zimmer Biomet Holdings IncZBH's earnings per share (EPS) for the previous quarter was USD 0.71. EPS for the next quarter is expected at USD 2.01.

What is the analyst rating for Zimmer Biomet Holdings Inc?

Based on the ratings of Zimmer Biomet Holdings Inc's stock from 29 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.